title: Regulation in review. Payment reform likely to continue for clinical laboratory services.
abstract: Payment for clinical laboratory services has been at the forefront of Medicare payment reform. Significant changes are likely to continue. These changes may eliminate the well-established practice of selling laboratory services to physicians at discount prices and may require laboratories to compete for the opportunity to participate in managed-care arrangements that result from federal health-care reform. Laboratories should restructure, as necessary, to ensure that they can provide testing at the lowest possible cost and to otherwise prepare for health policy changes.
authors.affiliation: Ober, Kaler, Grimes & Shriver, Baltimore.
authors.forename: R E
authors.initials: RE
authors.lastname: Mazer
mesh_terms: D019411:Clinical Laboratory Techniques / Q000191:economics; D005251:Fees, Medical / Q000331:legislation & jurisprudence; D007755:Laboratories, Hospital / Q000191:economics* / Q000331:legislation & jurisprudence; D006278:Medicare / Q000331:legislation & jurisprudence*; D012017:Referral and Consultation / Q000331:legislation & jurisprudence; D012051:Reimbursement Mechanisms / Q000331:legislation & jurisprudence*; D014481:United States